HCPCS Level IItemporaryActive
Q0235
Inj, monoclon antibody, 1 mg
BETOS: O1G
Effective: 2025-10-01
Description
Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
Statutory Exclusion
This code has a statutory exclusion from Medicare coverage.